Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Neil Allan Johnson Insider Profile

4 Followers

Neil Allan Johnson, Chief Executive Officer at Duke Capital, holds 8.07M shares in Duke Capital (Ticker: GB:DUKE), holds 1.06M shares in Marvel Biosciences Corp (Ticker: TSE:MRVL), holds 875.00K shares in Thiogenesis Therapeutics Corp (Ticker: TSE:TTI). Most recently, Neil Allan Johnson Sold ― shares of Duke Capital on Aug 17, 2026 for an estimated value of 41.33K .

Neil Allan Johnson's Trading History

DUKEDuke Capital		Aug 17, 2026Chief Executive OfficerInformative Sell41.33K£1.59M
MRVLMarvel Biosciences Corp		Apr 15, 2025DirectorInformative Buy75.38KC$121.67K
TTIThiogenesis Therapeutics Corp		Apr 01, 2022Executive, Ten Percent OwnerUninformative Sell12.50KC$546.88K
DCFDifference Cap Financial		Apr 16, 2014―Informative Buy93.75KC$2.61M
CCORFCanaccord Genuity		Mar 30, 2012Senior OfficerUninformative Buy1.98K$1.76M
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Neil Allan Johnson insider profile FAQ

What is the percentage of profitable transactions made by Neil Allan Johnson?
The percentage of profitable transactions made by Neil Allan Johnson is 53%.
What is the average return per transaction made by Neil Allan Johnson?
The average return per transaction made by Neil Allan Johnson is 5.20%.
What stocks does Neil Allan Johnson hold?
Neil Allan Johnson holds: GB:DUKE, CCORF, TSE:DCF, TSE:MRVL, TSE:TTI stocks.
What was Neil Allan Johnson’s latest transaction?
Neil Allan Johnson’s latest transaction was an Informative Sell of 41.33K .
What was Neil Allan Johnson's most profitable transaction?
Neil Allan Johnson’s most profitable transaction was an Informative Buy of TSE:MRVL stock on August 21, 2024. The return on the trade was 86.90%.
What is Neil Allan Johnson's role in Duke Capital?
Neil Allan Johnson's role in Duke Capital is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.